In addition, Logistic regression analysis including variables presented in Table S3 revealed that DLX5 hypermethylation may be acted as a negative risk factor independently affecting CR in whole‐cohort AML (P = .067; Table S3). This evidence concerns the gene DLX5 and acute myeloid leukemia.